The World Bank Implementation Status & Results Report Niger COVID-19 Emergency Response Project (P173846) Niger COVID-19 Emergency Response Project (P173846) WESTERN AND CENTRAL AFRICA | Niger | Health, Nutrition & Population Global Practice | IBRD/IDA | Investment Project Financing | FY 2020 | Seq No: 5 | ARCHIVED on 29-Jul-2022 | ISR52434 | Implementing Agencies: Ministry of Planning, Ministry of Public Health, Population and Social Affairs, Republic of Niger Key Dates Key Project Dates Bank Approval Date: 13-Apr-2020 Effectiveness Date: 08-Jul-2020 Planned Mid Term Review Date: 17-Oct-2022 Actual Mid-Term Review Date: 01-Jul-2022 Original Closing Date: 30-Apr-2022 Revised Closing Date: 31-Dec-2024 pdoTable Project Development Objectives Project Development Objective (from Project Appraisal Document) To prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness in Niger Has the Project Development Objective been changed since Board Approval of the Project Objective? No Components Table Name Component 1: Emergency COVID-19 Response:(Cost $61.35 M) Component 2: Communication campaign, community engagement and Behavior change:(Cost $4.00 M) Component 3: Implementation Management and Monitoring and Evaluation:(Cost $4.50 M) Overall Ratings Name Previous Rating Current Rating Progress towards achievement of PDO Satisfactory Satisfactory Overall Implementation Progress (IP) Moderately Satisfactory Moderately Satisfactory Overall Risk Rating Substantial Substantial Implementation Status and Key Decisions At mid-term review stage and based on the recorded implementation progress and the likelihood of achieving the project outcomes, both the implementation Progress (IP) and the Development Objectives (DO) are rated satisfactory. The second additional financing in the amount of US$26.7 million was approved on June 20, 2022, bringing the total project financing to US$69.85 million. All parent project financing has been disbursed or committed. COVID-19 vaccination status: The response measures must be reinforced as the rate of vaccination is still low; the last vaccination campaign (sixth campaign) was just completed. Furthermore, the strategies of vacci-drones and mobile sites have shown promising results and have facilitated the country to double its vaccination coverage. As of July 17, Niger has recorded 12 percent of the total population to be fully vaccinated (i.e. 2,860,989 people) against the national target to cover 14,833,403 people (i.e. 58.41 percent of the total population). 7/29/2022 Page 1 of 9 The World Bank Implementation Status & Results Report Niger COVID-19 Emergency Response Project (P173846) MPA Program Development Objective MPA PDO Table The Program Development Objective is to prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness MPA Table Multiphase Programmatic Approach (MPA) Status MPA Table Body The Additional Financing (MPA AF-V) to the COVID-19 Strategic Preparedness and Response Program utilizing the Multiphase Programmatic Approach (“Global COVID-19 MPA”) was approved by the Board on October 13, 2021. The AF-V was approved with an envelope of US$12 billion ($6 billion from IDA and $6 billion from IBRD) in financing. On June 30, 2021, President Malpass announced the expansion of financing available for COVID-19 vaccine financing to $20 billion over the next 18 months, adding $8 billion to the previously announced $12 billion. This financing is critical to expand affordable and equitable financing for vaccine purchase and deployment. The AF-V is expected to enable vaccination for up to 750 million people, with potential surge capacity for an additional 250 million people in the poorest countries (depending on the delivered price of approved vaccines) while scaling support to strengthen immunization delivery, with design flexibility at the country level. The AF-V is a scale-up of planned vaccination activities anticipated and supported under the Global COVID-19 MPA and a key contribution to the WBG’s overall COVID-19 response. As of July 15, 2022, the Bank has approved 115 operations (including MPA-V operations) to support vaccine procurement and rollout in 78 countries amounting to $10.1 billion. The 115 operations approved, include 6 operations that involved restructuring of parent projects (Bhutan, Cameroon, North Macedonia, Philippines, and Pakistan) and in the case of Lebanon, restructuring of the Health Resilience Project. Of the 115 approved operations: (i) 64 are in Africa – 29 in AFE and 35 in AFW; (ii) 9 in East Asia and the Pacific; (iii) 11 in Europe and Central Asia; (iv) 13 in Latin America and the Caribbean; (v) 9 in Middle East and North Africa; and (vi) 9 in South Asia. Thirty-four (34) operations have been approved so far this Calendar Year. Fifty-nine (59) projects are disbursing. Total disbursements as of July 15, 2022, under these projects amount to US$3.98 billion or 40% of overall commitments. Disbursements under MPA-V operations are included in this total while disbursements under the six restructured projects are counted under parent projects. Twenty-one (21) operations have disbursed over 70% of their commitments. Out of the 21, nine have disbursed 90%. Retroactive Financing (RF) represents 39% of overall commitments. High RF has been authorized under different operations Indonesia and Ukraine (100%), Panama and Turkey (90%), Argentina and Guyana (80%), and Belize, Iraq and Sri Lanka (70%). Three (3) new operations are under various stages of processing. As with the MPA operations, streamlined procedures, delegated approval, coupled with flexible project design, and intensified efforts across the Bank have contributed to the rapid design and processing of the operations. Ninety-seven (97) loan/financing agreements have been signed. Also, eighty-seven (87) loan/financing agreements have become effective; several others are expected to become effective in the coming weeks. Implementation of the AF-V operations, as with MPA operations is facing challenges as several countries are still under different levels of mobility restrictions and counterparts and Bank teams are operating in a hybrid environment with some days at the office and some at home. Virtual missions have continued to be the norm in some countries. Countries are continuing to deal with sharp increases of infections, as the Omicron variant continues to spread rapidly among populations. The omicron variant spread rapidly across the world, out-competing former variants soon after it was first detected in November, 2021. Risks Systematic Operations Risk-rating Tool Risk Category Rating at Approval Previous Rating Current Rating 7/29/2022 Page 2 of 9 The World Bank Implementation Status & Results Report Niger COVID-19 Emergency Response Project (P173846) Political and Governance High Substantial Substantial Macroeconomic High Substantial Substantial Sector Strategies and Policies Moderate Moderate Moderate Technical Design of Project or Program Substantial Moderate Moderate Institutional Capacity for Implementation and Moderate Substantial Substantial Sustainability Fiduciary High Substantial Substantial Environment and Social Substantial Substantial Substantial Stakeholders Moderate Substantial Substantial Other -- Substantial Substantial Overall Substantial Substantial Substantial Results PDO Indicators by Objectives / Outcomes To prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for p IN01171191 ►Efficiency of a public health coordination mechanism for COVID-19 (Yes/No, Custom) Baseline Actual (Previous) Actual (Current) End Target Value No Yes Yes Yes Date 24-Mar-2020 14-Feb-2022 14-Feb-2022 31-Dec-2024 Country has established its coordination mechanism for COVID-19 with daily reporting of different Comments: commissions IN01171192 ►Suspected cases of COVID-19 cases reported and investigated based on national guidelines (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 99.81 99.81 100.00 Date 24-Mar-2020 14-Feb-2022 14-Feb-2022 30-Apr-2022 Numerator: Number of suspected cases of COVID-19 cases reported and investigated based on national Comments: guidelines Denominator: Number of of suspected cases of COVID-19 cases reported and investigated IN01171193 ►Laboratories with trained staff and consumables for collecting COVID-19 samples and transporting to the National Public Health Llaboratory (Centre de Recherche Médicale et Sanitaire, CERMES) (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 17.00 17.00 20.00 Date 24-Mar-2020 14-Feb-2022 14-Feb-2022 31-Dec-2024 7/29/2022 Page 3 of 9 The World Bank Implementation Status & Results Report Niger COVID-19 Emergency Response Project (P173846) Comments: Cumulative targeted laboratories equipped with COVID-19 diagnostic equipment IN01171194 ►Targeted regions with pandemic preparedness and response plans per Ministry of Public Health Guidelines (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 100.00 100.00 100.00 Date 24-Mar-2020 14-Feb-2022 14-Feb-2022 31-Dec-2024 Numerator: number of targeted regions with pandemic level response plan according to Ministry of Public Comments: Health guidelines. Denominator: number of targeted regions IN01171195 ►Population vaccinated, which is included in the priority population targets defined in national plan (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 4.20 4.20 15.00 Date 12-Mar-2021 14-Feb-2022 14-Feb-2022 31-Dec-2024 IN01171196 Population vaccinated, which is included in the priority population targets defined in national plan - Female (Percentage, Custom Breakdown) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 1.50 1.50 6.00 Date 11-Jun-2021 14-Feb-2022 14-Feb-2022 31-Dec-2024 Intermediate Results Indicators by Components Component 1: Emergency COVID-19 Response IN01171199 ►Personal protective equipment (PPE) kits delivered to health facilities (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 500,000.00 500,000.00 12,000.00 Date 24-Mar-2020 14-Feb-2022 14-Feb-2022 31-Dec-2024 Comments: Cumulative number of PPE kits distributed to health facilities IN01171202 ►Health staff trained in infection prevention per MOH-approved protocols (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 300.00 300.00 600.00 7/29/2022 Page 4 of 9 The World Bank Implementation Status & Results Report Niger COVID-19 Emergency Response Project (P173846) Date 24-Mar-2020 14-Feb-2022 14-Feb-2022 31-Dec-2024 Comments: Cumulative number of staff receiving infection prevention control (IPC) or similar training via the project IN01171204 ►Laboratories with trained staff and consumables for collecting COVID-19 samples and transporting to National Public Health laboratory (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 17.00 17.00 12.00 Date 24-Mar-2020 14-Feb-2022 14-Feb-2022 31-Dec-2024 IN01171207 ►Targeted healthcare facilities with clinical capacity for COVID-19 patients (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 56.00 56.00 62.00 Date 24-Mar-2020 14-Feb-2022 14-Feb-2022 31-Dec-2024 Numerator: Total number of targeted healthcare facilities with capacity to treat COVID-19 patients Comments: Denominator: Total number of targeted health care facilities for COVID-19 patients IN01171208 ►Doses of eligible COVID-19 vaccines delivered in-country (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 0.00 2,000,000.00 Date 11-Jun-2021 14-Feb-2022 14-Feb-2022 31-Dec-2024 IN01171209 ►People trained on the installation, monitoring and maintenance of the cold chain equipment (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 0.00 200.00 Date 12-Mar-2021 14-Feb-2022 14-Feb-2022 31-Dec-2024 IN01171210 Women trained on the installation, monitoring and maintenance of the cold chain equipment-Female (Number, Custom Breakdown) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 0.00 100.00 Date 11-Jun-2021 14-Feb-2022 14-Feb-2022 31-Dec-2024 IN01171211 ►Expansion of functioning cold chain equipment and stored vaccines (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 0.00 150.00 7/29/2022 Page 5 of 9 The World Bank Implementation Status & Results Report Niger COVID-19 Emergency Response Project (P173846) Date 12-Mar-2021 14-Feb-2022 14-Feb-2022 31-Dec-2024 IN01171212 Expansion of functioning cold chain equipment and stored vaccines in urban, nomadic and desert areas- nomadic and desert areas (Number, Custom Breakdown) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 0.00 60.00 Date 04-Jun-2021 14-Feb-2022 14-Feb-2022 31-Dec-2024 IN01171213 ►Oxygen plant installed and functional (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 0.00 3.00 Date 29-Mar-2022 29-Mar-2022 29-Mar-2022 31-Dec-2024 IN01171214 ►Vaccination centers with a female vaccinator present (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 0.00 100.00 Date 15-Mar-2022 15-Mar-2022 15-Mar-2022 15-Mar-2022 Component 2: Communication campaign, community engagement and Behavior change IN01171197 ►Country has developed a communication and risk communication plan including community engagement strategies (Yes/No, Custom) Baseline Actual (Previous) Actual (Current) End Target Value No Yes Yes Yes Date 24-Mar-2020 14-Feb-2022 14-Feb-2022 31-Dec-2024 Comments: Existence of a communication and risk communication plan IN01171200 ►Radio Stations broadcast COVID-19 risk communication message (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 12.00 12.00 90.00 Date 24-Mar-2020 14-Feb-2022 14-Feb-2022 31-Dec-2024 Cumulative number of COVID-19 sensitization campaigns conducted as per contextualized their risk Comments: communication and community engagement strategies IN01171203 ►Gender sensitive educational materials on COVID-19 vaccines distributed (Yes/No, Custom) 7/29/2022 Page 6 of 9 The World Bank Implementation Status & Results Report Niger COVID-19 Emergency Response Project (P173846) Baseline Actual (Previous) Actual (Current) End Target Value No No No Yes Date 07-May-2021 14-Feb-2022 14-Feb-2022 31-Dec-2024 IN01171206 ►Grievances received and addressed within the defined timeframe (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 2.00 2.00 90.00 Date 11-Jun-2021 14-Feb-2022 14-Feb-2022 31-Dec-2024 Component 3: Implementation Management and Monitoring and Evaluation IN01171198 ►M&E system established and implemented to monitor project progress (Yes/No, Custom) Baseline Actual (Previous) Actual (Current) End Target Value No Yes Yes Yes Date 24-Mar-2020 14-Feb-2022 14-Feb-2022 31-Dec-2024 Comments: M&E system has been established and implemented to monitor project progress IN01171201 ►Number of healthcare professionals and district investigation officers trained on detection and reporting, or investigation of AEFIs (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 0.00 200.00 Date 29-Mar-2022 29-Mar-2022 29-Mar-2022 31-Dec-2024 IN01171205 Healthcare professionals and district investigation officers trained on detection and reporting, or investigation of AEFIs- Female (Number, Custom Breakdown) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 0.00 100.00 Date 17-May-2022 17-May-2022 17-May-2022 31-Dec-2024 Performance-Based Conditions Data on Financial Performance Disbursements (by loan) 7/29/2022 Page 7 of 9 The World Bank Implementation Status & Results Report Niger COVID-19 Emergency Response Project (P173846) Project Loan/Credit/TF Status Currency Original Revised Cancelled Disbursed Undisbursed % Disbursed P173846 IDA-66200 Effective USD 6.98 6.98 0.00 2.87 4.13 41% P173846 IDA-69570 Effective USD 14.00 14.00 0.00 0.55 11.55 4.5% Not P173846 IDA-71880 USD 13.35 13.35 0.00 0.00 13.43 0% Effective P173846 IDA-D6180 Effective USD 6.98 6.98 0.00 7.42 0.00 100% P173846 IDA-D8700 Effective USD 14.00 14.00 0.00 0.80 12.16 6.2% Not P173846 IDA-E1040 USD 13.35 13.35 0.00 0.00 13.36 0% Effective P173846 TF-B5944 Effective USD 1.20 1.20 0.00 0.00 1.20 0% Key Dates (by loan) Project Loan/Credit/TF Status Approval Date Signing Date Effectiveness Date Orig. Closing Date Rev. Closing Date P173846 IDA-66200 Effective 13-Apr-2020 08-May-2020 08-Jul-2020 30-Apr-2022 31-Dec-2024 P173846 IDA-69570 Effective 25-Jun-2021 27-Aug-2021 17-Dec-2021 31-Dec-2024 31-Dec-2024 Not P173846 IDA-71880 20-Jun-2022 -- -- 31-Dec-2024 31-Dec-2024 Effective P173846 IDA-D6180 Effective 13-Apr-2020 08-May-2020 08-Jul-2020 30-Apr-2022 31-Dec-2024 P173846 IDA-D8700 Effective 25-Jun-2021 27-Aug-2021 17-Dec-2021 31-Dec-2024 31-Dec-2024 Not P173846 IDA-E1040 20-Jun-2022 -- -- 31-Dec-2024 31-Dec-2024 Effective P173846 TF-B5944 Effective 25-Jun-2021 25-Aug-2021 17-Dec-2021 30-Apr-2022 30-Apr-2023 Cumulative Disbursements 7/29/2022 Page 8 of 9 The World Bank Implementation Status & Results Report Niger COVID-19 Emergency Response Project (P173846) Restructuring History Level 2 Approved on 27-Apr-2022 Related Project(s) P176345-Niger COVID-19 Emergency Response Project - Additional Financing ,P178894-Niger COVID-19 Emergency Response Project- Second Additional Financing 7/29/2022 Page 9 of 9